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New Migraine with Visual Disturbance after Cryoballoon Ablation
of Atrial Fibrillation
Annupreet Nadha, Eric S Williams
Cardiac Electrophysiology, Swedish Heart & Vascular Institute, Swedish Medical Center, Seattle, WA 550 17th Avenue, Suite
450; Seattle, WA, USA 98122.
Abstract

We report the case of a 58-year-old woman who developed a headache and visual disturbances after a cryoballoon ablation procedure for
atrial fibrillation at our institution. She presented to the emergency department four days post ablation and was admitted the hospital for
overnight observation. Serial neurological examinations and neuroimaging were unremarkable for stroke or transient ischemic attack. The
patient had some brief transient visual changes which resolved completely after several days, with no further clinical sequelae. She followed
up in the outpatient neuro-ophthalmology clinic and had a normal visual field examination. She was given a diagnosis of new onset migraine
with visual aura.

Case Report

A 58-year-old woman with a history of hyperlipidemia and
drug-refractory paroxysmal atrial fibrillation was referred to our
electrophysiology practice for catheter ablation. Her preoperative
medications only included digoxin and aspirin, and these were not
withheld prior to the procedure. A preoperative transesophageal
echocardiogram confirmed the absence of thrombus in the left
atrial appendage. Transseptal catheterization of the left atrium
was performed with the aid of intracardiac echocardiography
(AcuNav, Siemens Medical Solutions, Inc., Mountain View, CA)
by direct puncture of the mid-posterior fossa ovalis with a 71-cm
Brockenbrough transseptal needle (BRK-1, St. Jude Medical, St.
Paul, MN) and an 8.5-French 63-cm guiding introducer sheath
(SL-1, St. Jude Medical), followed by an over-the-wire exchange for
a 12-French steerable sheath (FlexCath Advance, Medtronic Inc.,
Minneapolis, MN). Unfractionated heparin was administered via
intravenous boluses started prior to transseptal puncture, followed by
a continuous infusion to achieve activated clotting times >300 seconds
during ablation in the left atrium. Pulmonary vein isolation and
superior vena cava isolation were performed under general anesthesia
using a 28-mm cryoballoon ablation catheter (Arctic Front Advance,
Medtronic Inc.) and a 4-mm radiofrequency ablation catheter (Blazer
II, Boston Scientific, Natick, MA), respectively. Left atrial mapping
and ablation were completed within 75 minutes exclusively with
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the cryoballoon sheath and catheter, and an additional 15 minutes
were spent with the sheath and a radiofrequency ablation catheter in
the right atrium to complete superior vena cava isolation. Heparin
anticoagulation was then reversed with protamine, and six hours post
procedure she was started on therapeutic oral anticoagulation with
rivaroxban. She was discharged the next day in good condition.
On postoperative day#1, she developed a left occipital headache
described as sharp but non-pulsatile that was initially mild in severity
and relieved with oral acetaminophen. On post-operative day #3, the
patient developed the sudden onset of visual symptoms described as
bright flashes of light accompanied by blurriness of her peripheral
vision bilaterally. Over the next 45 minutes, her vision normalized,
at which time she developed recurrence of her left-sided headache.
She had the return of similar visual symptoms the following day, and
presented to the emergency department. Her blood pressure was
113/73 with a pulse of 94 beats per minute. She was alert and oriented
to time, person and place. Her neurologic examination was non-focal.
Laboratory studies, including complete blood count, renal function,
and serum electrolytes were all normal. Serum digoxin level was
0.6 ng/mL. Electrocardiography and cardiac monitoring confirmed
normal sinus rhythm. She underwent computed tomography (CT)
imaging of her head, which showed no intracranial hemorrhage or
mass lesion; CT angiography demonstrated no intracranial vascular
stenosis. Magnetic resonance imaging of her brain was performed,
which revealed only minimal nonspecific white matter disease, and
no evidence of acute or subacute infarction [Figure 1]. Visualized
portions of the orbits, optic nerves and visual pathways were also
normal.
She was evaluated by the neurology service, who felt her
presentation was consistent with a new onset migraine with visual
aura. She had no previous history of migraine headaches. She did
not have clinical evidence of an ischemic stroke or transient ischemic
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Magnetic resonance imaging (MRI) of the brain obtained post
ablation

attack after overnight observation. She was discharged home in good
condition. Over the next several days, she experienced some transient
blurriness in her vision lasting approximately 45 minutes without
headache or loss of peripheral vision. She had a follow-up visit in
the neuro-ophthalmology clinic one week postoperatively, and both
fundoscopic examination and visual field testing were within normal
limits [Figure 2]. She had a follow-up visit in the cardiology clinic
one month postoperatively, and described no further clinical sequelae.

Discussion

Catheter ablation of atrial fibrillation (AF) has evolved as a safe
and highly effective treatment for drug-refractory symptomatic
AF.[1]Over the last few years, cryoballoon ablation has become an
increasingly utilized technique for the treatment of AF in the
electrophysiology laboratory.[2] There have been a number of reports
describing headache and migraines after AF ablation, including
studies that suggest an increased incidence during and after
cryoballoon AF ablation.[3]-[7]
There appears to be a specific link between the iatrogenic atrial septal
defect (IASD) caused by transseptal puncture and the development
of post-procedure migraines. In a series of 571 consecutive patients
undergoing transseptal catheterization at the time of catheter ablation
for left-sided cardiac arrhythmias at a single center, isolated migraine
aura occurred with an incidence of about 0.5%. In these patients,
transient and reversible visual symptoms were noted in the first week,
with a negative workup for stroke or transient ischemic attack in all
cases.[3] A larger series of 2,069 patients, undergoing radiofrequency
catheter ablation for AF, saw a 2.3% incidence of post-procedure
headaches, with new-onset definite migraines described in 1.1% of
patients.[5] Another study did find an association between new or
worsening migraine symptoms and silent cerebral infarcts on brain
MRI after AF ablation, which suggest thromboembolism and/
or hypercoagulability may play a role in the development of postprocedure migraines. [8] In fact, in this study, therapeutic levels of
warfarin anticoagulation maintained during the peri-procedural
period were associated with freedom from migraine. Specifically, it
is hypothesized that IASD, similar to a native patent foramen ovale,
can result in paradoxical embolism of platelets, thrombin and other
substances that might contribute to the pathogenesis of migraine. [9]
Cryoballoon AF ablation is performed using a larger transseptal
sheath (12 French inner diameter, as opposed to 8 or 8.5 French for
radiofrequency AF ablation), which may be associated with a higher
risk of persistent post-procedure IASD.[10] In a study of 87 consecutive
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patients followed for three months after cryoballoon ablation, 8%
reported new symptoms of headache with ocular symptoms such
as scotoma.[4] Most symptoms had disappeared when patients were
reevaluated in the outpatient clinic three months after the ablation
procedure. To the extent that the larger transseptal hole may allow
for a greater propensity for thrombo-embolism and potentially
migraine symptoms, anticoagulation strategies such as uninterrupted
and therapeutic pre-procedure oral anticoagulation and intravenous
heparinization prior to transseptal puncture, may be even more
important for cryoballoon AF ablation than for radiofrequency AF
ablation cases. Interestingly, in the study by Mohanty et al., there
were no cases of new migraine or silent cerebral infarcts in the cohort
that underwent AF ablation with therapeutic INR on the day of the
ablation procedure. Pre-procedure warfarin was not utilized in our
patient as she opted for an oral anticoagulant that would not require
INR monitoring. It is common practice in our institution to suspend
anticoagulation with a direct oral anticoagulant such as rivaroxaban
24 to 48 hours pre-procedure, or initiate it postoperatively in patients
who have not been previously anticoagulated. This practice is in
contradistinction to the management of our patients on warfarin,
which is not suspended pre-procedure, and may in retrospect have
increased the risk of post-procedure migraine in this patient. Recent
data on the use of direct oral anticoagulants during AF ablation
suggest that uninterrupted apixaban administration may be a feasible
and effective strategy in preventing thromboembolic events without
increasing the risk of major bleeding complications. [11]

Figure 2:

Visual field testing of left (left panel) and right (right panel) eyes
post ablation

Conclusions

Migraine with visual aura is an increasingly recognized postoperative
complication of AF catheter ablation procedures, and may be related
to the presence and size of transseptal sheaths used intraoperatively,
and the peri-procedural anticoagulant regimen. Neuroimaging
and a thorough ophthalmologic examination are necessary to rule
out potential thromboembolic and/or vascular causes in patients
presenting with acute visual disturbances post ablation.
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